Su‐Mei Cao

5.2k total citations · 2 hit papers
47 papers, 2.6k citations indexed

About

Su‐Mei Cao is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Su‐Mei Cao has authored 47 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 14 papers in Cancer Research and 13 papers in Molecular Biology. Recurrent topics in Su‐Mei Cao's work include Viral-associated cancers and disorders (17 papers), Head and Neck Cancer Studies (11 papers) and Cancer-related molecular mechanisms research (8 papers). Su‐Mei Cao is often cited by papers focused on Viral-associated cancers and disorders (17 papers), Head and Neck Cancer Studies (11 papers) and Cancer-related molecular mechanisms research (8 papers). Su‐Mei Cao collaborates with scholars based in China, United States and Sweden. Su‐Mei Cao's co-authors include Rui‐Hua Xu, Ruimei Feng, Haibo Qiu, Ming‐Huang Hong, Mengmeng Li, Qihong Huang, Yi‐Xin Zeng, Hua-Qing Min, Shang-Hang Xie and Wanqing Chen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Su‐Mei Cao

46 papers receiving 2.6k citations

Hit Papers

Current cancer situation in China: good or bad news from ... 2019 2026 2021 2023 2019 2021 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
    2019 1.2k citations Su‐Mei Cao, Rui‐Hua Xu et al. Cancer Communications profile →
  2. Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020
    2021 598 citations Haibo Qiu, Su‐Mei Cao et al. Cancer Communications profile →

Peers

Su‐Mei Cao
Jeffrey S. Chang Taiwan
Giannis Mountzios Greece
Kalyan Saginala United States
Kostas Syrigos Greece
Christina Fitzmaurice United States
Sunita Saxena India
Jiansong Ren China
Greta Carioli Italy
Adnan Ghafoor United States
E. Masuyer France
Jeffrey S. Chang Taiwan
Su‐Mei Cao
Citations per year, relative to Su‐Mei Cao Su‐Mei Cao (= 1×) peers Jeffrey S. Chang

Countries citing papers authored by Su‐Mei Cao

Since Specialization
Citations

This map shows the geographic impact of Su‐Mei Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐Mei Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐Mei Cao more than expected).

Fields of papers citing papers by Su‐Mei Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su‐Mei Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐Mei Cao. The network helps show where Su‐Mei Cao may publish in the future.

Co-authorship network of co-authors of Su‐Mei Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Su‐Mei Cao. A scholar is included among the top collaborators of Su‐Mei Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su‐Mei Cao. Su‐Mei Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yanwen, Zhonghua Liu, Yuqian Wang, et al.. (2025). Immunosequencing identifies signatures of T cell responses for early detection of nasopharyngeal carcinoma. Cancer Cell. 43(8). 1423–1441.e10. 3 indexed citations
2.
Cao, Su‐Mei, Mingfang Ji, Yong‐Qiao He, & Wei‐Hua Jia. (2024). Epidemiological studies of Epstein-Barr virus and associated diseases. Scientia Sinica Vitae. 54(12). 2224–2244. 1 indexed citations
3.
Vaccarella, Salvatore, Luigino Dal Maso, Wei Wei Liu, et al.. (2023). Mortality among papillary thyroid cancer patients by detection route: a hospital-based retrospective cohort study. European Thyroid Journal. 12(6). 3 indexed citations
4.
Yue, Caifeng, Chang Wang, Jiewei Chen, et al.. (2023). TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma. Cancer Science. 114(8). 3176–3189. 6 indexed citations
5.
Rumgay, Harriet, et al.. (2023). Nasopharyngeal Cancer Incidence and Mortality in 185 Countries in 2020 and the Projected Burden in 2040: Population-Based Global Epidemiological Profiling. JMIR Public Health and Surveillance. 9. e49968–e49968. 59 indexed citations
6.
Li, Mengmeng, Su‐Mei Cao, Niki Dimou, et al.. (2023). Association of Metabolic Syndrome With Risk of Lung Cancer. CHEST Journal. 165(1). 213–223. 19 indexed citations
7.
Chen, Yufeng, Ellen T. Chang, Qing Liu, et al.. (2022). Environmental Factors for Epstein-Barr Virus Reactivation in a High-Risk Area of Nasopharyngeal Carcinoma: A Population-Based Study. Open Forum Infectious Diseases. 9(5). ofac128–ofac128. 12 indexed citations
8.
Du, Jinlin, Yuyu Li, Sujin Zhou, et al.. (2022). Resistin Promotes Nasopharyngeal Carcinoma Metastasis through TLR4-Mediated Activation of p38 MAPK/NF-κB Signaling Pathway. Cancers. 14(23). 6003–6003. 10 indexed citations
9.
Qiu, Haibo, Su‐Mei Cao, & Rui‐Hua Xu. (2021). Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Communications. 41(10). 1037–1048. 598 indexed citations breakdown →
10.
Zhou, Xiang, Su‐Mei Cao, Yonglin Cai, et al.. (2021). A comprehensive risk score for effective risk stratification and screening of nasopharyngeal carcinoma. Nature Communications. 12(1). 5189–5189. 31 indexed citations
11.
Zhu, Qian‐Ying, Sisi Shan, Jinfang Yu, et al.. (2021). A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus. Nature Communications. 12(1). 6624–6624. 25 indexed citations
12.
Lin, Chuyang, Shang-Hang Xie, Tong Li, et al.. (2021). Association Between Traditional Herbal Diet and Nasopharyngeal Carcinoma Risk: A Prospective Cohort Study in Southern China. Frontiers in Oncology. 11. 715242–715242. 3 indexed citations
13.
Chen, Wenjie, Haiyun Wang, Xiaoxia Chen, et al.. (2021). Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population. BMC Cancer. 21(1). 651–651. 18 indexed citations
14.
Zhu, Juan, Xinxin Yan, Chengcheng Liu, et al.. (2020). Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing. Quality of Life Research. 30(3). 841–854. 31 indexed citations
15.
Hu, Ting, Chuyang Lin, Shang‐Hang Xie, et al.. (2019). Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivating Epstein‐Barr Virus: An analysis of a prospective study in southern China. Cancer Medicine. 8(5). 2561–2571. 25 indexed citations
16.
Xia, Yu, et al.. (2019). A Retrospective Cohort Study of Nasopharyngeal Carcinoma Screening and Hepatocellular Carcinoma Screening in Zhongshang City. Journal of Cancer. 10(8). 1909–1914. 3 indexed citations
17.
Liu, Qing, Qihong Huang, Yuqiang Lu, et al.. (2016). Time trend analysis of primary liver cancer incidence in Sihui county of Guangdong Province, China (1987–2011). BMC Cancer. 16(1). 796–796. 8 indexed citations
18.
19.
20.
Qian, Chao‐Nan, Changqing Zhang, Xiang Guo, et al.. (2000). Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma. Cancer. 88(2). 255–261. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey S. Chang Breakdown of academic impact, for papers by Giannis Mountzios Breakdown of academic impact, for papers by Kalyan Saginala Breakdown of academic impact, for papers by Kostas Syrigos Breakdown of academic impact, for papers by Christina Fitzmaurice Breakdown of academic impact, for papers by Sunita Saxena Breakdown of academic impact, for papers by Jiansong Ren Breakdown of academic impact, for papers by Greta Carioli Breakdown of academic impact, for papers by Adnan Ghafoor Breakdown of academic impact, for papers by E. Masuyer
Rankless by CCL
2026